Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

US Patent 8912335 · Granted Dec 16, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for reducing immune intolerance and treating autoimmune2025
Lipid nanoparticle formulations and compositions2025
Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugat2025
Compositions and methods for reducing immune intolerance and treating autoimmune2024
Small molecule inhibitors of ALDH and uses thereof2024
Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases2024
Compositions and methods for reducing immune intolerance and treating autoimmune2023
Glucosylceramide synthase inhibitors and therapeutic methods using the same2022
Ionizable cationic lipid for RNA delivery2021
Trinucleotide mRNA cap analogs2021
Substituted N-acetyl-L-cysteine derivatives and related compounds2021
Ionizable cationic lipid for RNA delivery2021